Phase II studies of different schedules and doses of the farnesyl transferase inhibitor tipifarnib (R115777, zarnestra, NSC-702818) for patients of age 70 or older with previously untreated acute myeloid leukemia (AML): A north American intergroup study (S0432)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Kopecky, KJ; Kirschbaum, MH; Tallman, MS; Larson, RA; Willman, CL; Slovak, ML; Gundacker, HM; Appelbaum, FR

Published Date

  • November 16, 2007

Published In

Volume / Issue

  • 110 / 11

Start / End Page

  • 136A - 136A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 49th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Atlanta, GA

Conference Start Date

  • December 8, 2007

Conference End Date

  • December 11, 2007